Delacretaz E, Kirshenbaum JM, Friedman PL
Prinzmetal's angina. Circulation. 2000 Mar 21; 101(11):E107-8.
Pierce GL, Seferlis C, Kirshenbaum J, Hartley LH
Lack of association of exercise testing with coronary stent closure. Am J Cardiol. 2000 Dec 01; 86(11):1259-61, A6.
Lack of association of exercise testing with coronary stent closure.
Platelet aggregation induced by streptokinase in the presence of specific antibodies. Circulation. 1987; 76(Suppl IV):IV-100.
Platelet aggregation induced by streptokinase in the presence of specific antibodies
Kirshenbaum JM, Flaherty JT, Bahr RD, Levine HJ, Loscalzo J, Schumacher R, Topol EJ, Wahr D, and Braunwald E
Coronary thrombolysis with low-dose synergistic combinations of prourokinase and recombinant tissue plasminogen activator. Circulation. 1990; 82((Suppl III):III-537.
Coronary thrombolysis with low-dose synergistic combinations of prourokinase and recombinant tissue plasminogen activator
Shemin RJ, Young P, Kirshenbaum JM, Mudge GH, Schoen F, DiSesa VJ, Cohn LH, Collins JJ
Acute rejection: Treatment results in a new heart transplant program. J Heart Transp. 1986; 5:53.
Acute rejection: Treatment results in a new heart transplant program
Kuo PC, Kirshenbaum JM, Gordon J, Laffel G, Young P, DiSesa VJ, Mudge GH, Vaughan DE
Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Am J Cardiol. 1989 Sep 15; 64(10):631-5.
Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients.
Kirshenbaum JM, Kloner RA, Antman EM, Braunwald E
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation. 1985 Oct; 72(4):873-80.
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol. 1985 Oct 23; 56(11):40F-48F.
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Thrombolysis and angioplasty in acute myocardial infarction. Management Options in Cardiology. 1989; 1:4-5.
Thrombolysis and angioplasty in acute myocardial infarction
Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ
A new Tc-99m-labeled myocardial imaging agent, hexakis (t-utylisonitrile-technetium (I) (Tc-99m TBI): initial experience in the human. J Nucl Med. 1984; 25:1350-1355.
A new Tc-99m-labeled myocardial imaging agent, hexakis (t-utylisonitrile-technetium (I) (Tc-99m TBI): initial experience in the human
Dempsey J, Gillis C, Sibicky S, Matta L, MacRae C, Kirshenbaum J, Faxon D, Churchill W
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population. Am J Health Syst Pharm. 2018 Sep 01; 75(17 Supplement 3):S63-S71.
Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population.
Goldszer RC, Moore ML, Hird L, Kirshenbaum JM, et al.
Process improvements to support eairler discaharge times on a cardiology serviece. J of Clinical Outcomes Management. 2003; 10:263-265.
Process improvements to support eairler discaharge times on a cardiology serviece
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human. J Nucl Med. 1984 Dec; 25(12):1350-5.
A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.
Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE
Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther. 1981 Mar; 29(3):318-21.
Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects.
Effect of large doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharm Ther. 1981; 29:318-321.
Effect of large doses of ascorbic acid on uric acid excretion by normal subjects
Fox RR, Laird CW, Kirshenbaum J, Meier H
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Effect of strain, sex, and circadian rhythm on rabbit serum bilirubin and iron levels. Proc Soc Exp Biol Med. 1974 Feb; 145(2):421-7.
Effect of strain, sex, and circadian rhythm on rabbit serum bilirubin and iron levels.
Shook TL, Kirshenbaum JM, Hundley RF, Shorey JM, Lamas GA
Ethanol intoxication complicating intravenous nitroglycerin therapy. Ann Intern Med. 1984 Oct; 101(4):498-9.
Ethanol intoxication complicating intravenous nitroglycerin therapy.
Kirshenbaum JM, Lorell BH, Schoen FJ, Bettmann MA, Thompson GB
Journal of the American College of Cardiology
Angioinvasive pulmonary aspergillosis: presentation as massive pulmonary saddle embolism in an immunocompromised patient. J Am Coll Cardiol. 1985 Aug; 6(2):486-9.
Angioinvasive pulmonary aspergillosis: presentation as massive pulmonary saddle embolism in an immunocompromised patient.
Brasier AR, Macklis JD, Vaughan D, Warner L, Kirshenbaum JM
Myopericarditis as an initial presentation of meningococcemia. Unusual manifestation of infection with serotype W135. Am J Med. 1987 Mar 23; 82(3 Spec No):641-4.
Myopericarditis as an initial presentation of meningococcemia. Unusual manifestation of infection with serotype W135.
Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Dozlowski J, English RJ, Jones AG
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99-m hexakis (t-butylisonitrile) technetium (I) (TBI), a new myocardial imaging agent. European J Nucl Med. 1986; 12:219-225.
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99-m hexakis (t-butylisonitrile) technetium (I) (TBI), a new myocardial imaging agent
Streptokinase-induced, antibody-mediated platelet aggregation: a potential cause of clot propagation in vivo. J Am Coll Cardiol. 1988 Jun; 11(6):1343-8.
Streptokinase-induced, antibody-mediated platelet aggregation: a potential cause of clot propagation in vivo.
Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P
Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988 Jan; 81(1):21-31.
Responses of coronary arteries of cardiac transplant patients to acetylcholine.
Hickey ML, Rossi L, Vander Vliet M, Kirshenbaum JM, Komaroff AL, Lee TH, Burstin H
Gender differences in health status prior to coronary revascularization. Circulation. 1994; 90(Suppl I):I-349.
Gender differences in health status prior to coronary revascularization
Levin DC, Boxt LM, Abben R, Garnic JD, Kirshenbaum JM, Adler D, Shook T, Friedman P, Ganz P
Sequential balloon technique in angioplasty of severe coronary arterial obstructions. Am J Cardiol. 1985 Nov 01; 56(12):789-91.
Sequential balloon technique in angioplasty of severe coronary arterial obstructions.
Kirshenbaum JM, Antman E, McGowan N, Kloner P
Use of esmolol in patients with acute myocardial ischemia and contraindications to beta blockade. J Am Coll Cardiol. 1987; 9(Suppl A):24A.
Use of esmolol in patients with acute myocardial ischemia and contraindications to beta blockade
Berg DD, Kirshenbaum J, Gay E, Vaidya A, Loscalzo J
A Dangerous Detour. N Engl J Med. 2019 Mar 28; 380(13):e18.
Berg DD, Kirshenbaum JM, Gay E, Miller AL, Loscalzo J
A Dangerous Detour. N Engl J Med. 2019 Apr 04; 380(14):1360-1365.
Samuel A. Levine Professor of Medicine; Hersey Distinguished Professor of the Theory and Practice of Physic
Katz Silver Family Professor of Medicine in the Field of Outcomes Research in Cardiology
Chai PR, Ferro EG, Kirshenbaum JM, Hayes BD, Culbreth SE, Boyer EW, Erickson TB
Journal of medical toxicology : official journal of the American College of Medical Toxicology
Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic. J Med Toxicol. 2020 07; 16(3):314-320.
Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic.
In Reply to "Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?" J Med Toxicol. 2021 01; 17(1):85-86.
In Reply to "Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?"
Associate Professor of Emergency Medicine
Bittencourt MS, Christman MP, Hulten E, Divakaran S, Skali H, Kwong RY, Hainer J, Forman DE, Kirshenbaum JM, Dorbala S, Di Carli MF, Blankstein R
Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists.
Hucker WJ, Chatzizisis YS, Steigner ML, Winters GL, Kirshenbaum JM
Myocardial catastrophe: a case of sudden, severe myocardial dysfunction. Circulation. 2014 Sep 02; 130(10):854-62.
Myocardial catastrophe: a case of sudden, severe myocardial dysfunction.
Horgan SJ, Waller AH, Veeranna V, Kirshenbaum J, Dorbala S, Di Carli MF
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Utility of multimodality imaging in suspected prosthetic valve endocarditis. J Nucl Cardiol. 2016 Apr; 23(2):316-20.
Utility of multimodality imaging in suspected prosthetic valve endocarditis.
Heart disease and stroke : a journal for primary care physicians
Therapy for acute myocardial infarction: an update. Heart Dis Stroke. 1992 Jul-Aug; 1(4):211-7.
Therapy for acute myocardial infarction: an update.
DeFilippis EM, Vaidya A, Ramani S, French C, Kirshenbaum JM
Under Pressure. N Engl J Med. 2017 Mar 30; 376(13):e23.
Simon DI, Liu CB, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Popma JJ
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv. 2001 Apr; 52(4):425-32.
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban.
Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003 Jan; 145(1):42-6.
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.
Bhatia S, Kirshenbaum JM, Shemin R, Cohn L, Collins J, DiSesa V, Mudge G, St. John Sutton M
Time course of resolution of pulmonary hypertension and right ventricular remodeling after cardiac transplantation. J Am Coll Cardiol. 1987; 9(Suppl A):31A.
Time course of resolution of pulmonary hypertension and right ventricular remodeling after cardiac transplantation
Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol. 1994 Dec; 24(7):1602-10.
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
Loscalzo J, Wharton TP, Kirshenbaum JM, Levine HJ, Flaherty JT, Topol EJ, Ramaswamy K, Kosowsky BD, Salem DN, Ganz P
Clot-selective coronary thrombolysis with pro-urokinase. Circulation. 1989 Apr; 79(4):776-82.
Clot-selective coronary thrombolysis with pro-urokinase.
Kirshenbaum JM, Kloner RF, McGowan N, Antman EM
Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol. 1988 Sep; 12(3):773-80.
Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Therapy of Acute Myocardial Infarction: An Update. Heart Disease and Stroke. 1992; 1:211-217.
Therapy of Acute Myocardial Infarction: An Update. Heart Disease and Stroke
Punnoose LR, Roh JD, Hu S, Udell JA, Wagle N, Kirshenbaum JM, Lacasce AS
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Cardiac presentation of anaplastic large-cell lymphoma. J Clin Oncol. 2010 Jul 01; 28(19):e314-6.
Cardiac presentation of anaplastic large-cell lymphoma.
Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Kozlowski J, English RJ, Jones AG
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent. Eur J Nucl Med. 1986; 12(5-6):219-25.
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent.
Wheeler JE, Enterline HT, Roseman JM, Tomasulo JP, McIlvaine CH, Fitts WT, Kirshenbaum J
Lobular carcinoma in situ of the breast. Long-term followup. Cancer. 1974 Sep; 34(3):554-63.
Lobular carcinoma in situ of the breast. Long-term followup.
Cannon CP, Thompson B, McCabe CH, Mueller HS, Kirshenbaum JM, Herson S, Nasmith JB, Chaitman BR, Braunwald E
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials. Am J Cardiol. 1995 May 15; 75(15):977-81.
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials.
Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, Palmeri S, Dangoisse V, Flaker GC, Davis V, Chaitman, Wackers FJTh, Zaret BL, Gibson CM, Poole WK, Braunwald E
Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial. Circulation. 1993; 88(Suppl I):I-291.
Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial
Kirshenbaum JM, Bahr RD, Flaherty JT, Gurewich V, Levine HJ, Loscalzo J, Schumacher RR, Topol EJ, Wahr DW, Braunwald E
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group. Am J Cardiol. 1991 Dec 15; 68(17):1564-9.
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.
Successful treatment of prosthetic tricuspid valve thrombosis with short-course recombinant tissue-type plasminogen activator. Am Heart J. 1990 Oct; 120(4):975-7.
Successful treatment of prosthetic tricuspid valve thrombosis with short-course recombinant tissue-type plasminogen activator.
Lee RT, Bhatia SJ, Kirshenbaum JM, Friedman PL
Left ventricular tamponade: echocardiographic and hemodynamic manifestations. Clin Cardiol. 1989 Feb; 12(2):102-4.
Left ventricular tamponade: echocardiographic and hemodynamic manifestations.
Marchini J, Morrow D, Resnic F, Manica A, Kirshenbaum J, Cannon C, Croce K
An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention. Crit Pathw Cardiol. 2010 Dec; 9(4):192-8.
An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention.
Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P
Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation. 1986 Aug; 74(2):330-9.
Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty.
Stamler JS, Vaughan DE, Rudd MA, Mudge GH, Kirshenbaum J, Young P, Alexander RW, Loscalzo J
Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol. 1988 Dec 01; 62(17):1268-72.
Frequency of hypercholesterolemia after cardiac transplantation.
Lin CB, Popma JJ, Chan S, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Simon DI.
Comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergiong percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Circulation. 2000; 102:II-418.
Comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergiong percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban
Campbell S, Holman BL, Kirshenbaum JM, Jones AG, Lister-James J, Davison, A. Antman EM
Radionuclide imaging of myocardial infarction using Tc-99m TBI. Circulation. 1985; 72(Suppl III):III-443.
Radionuclide imaging of myocardial infarction using Tc-99m TBI
Bhatia SJ, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ, Young PJ, Mudge GH, Sutton MG
Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 1987 Oct; 76(4):819-26.
Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation.
Nonthrombolytic intervention in acute myocardial infarction. Am J Cardiol. 1989 Jul 18; 64(4):25B-28B.
Nonthrombolytic intervention in acute myocardial infarction.
Maron BA, Goldhaber SZ, Sturzu AC, Rhee DK, Ali BS, Shah PB, Kirshenbaum JM
Catheter-directed thrombolysis for giant right atrial thrombus. Circ Cardiovasc Imaging. 2010 Jan; 3(1):126-7.
Catheter-directed thrombolysis for giant right atrial thrombus.
Manji N, Hulyalkar AR, Keroack MA, Vekshtein VI, Kirshenbaum JM, Sugarman DI, Chopra S
The American journal of gastroenterology
Cutaneous pseudo abscesses: an unusual presentation of severe pancreatitis. Am J Gastroenterol. 1988 Feb; 83(2):177-9.
Cutaneous pseudo abscesses: an unusual presentation of severe pancreatitis.
Sung RJ, Blanski L, Kirshenbaum J, MacCosbe P, Turlapaty P, Laddu AR
Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia. J Clin Pharmacol. 1986 03; 26(S1):A15-A26.
Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Physicians on Line: Controversies in Cardiology CME
Management of Stable and Unstable Angina Pectoris. Physicians on Line: Controversies in Cardiology CME. 1998.
Management of Stable and Unstable Angina Pectoris
Mitral valve surgery: Reconstruction vs. Replacement. Lifeline. 1985; 3:1-16.
Mitral valve surgery: Reconstruction vs. Replacement
Stone PH, Thompson B, Zaret BL, Chaitman B, Gibson RS, Schweiger MJ, Steingart R, Kirshenbaum J, Thompson C, Fung A, McCabe CH, Knatterud GL, Braunwald E
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study. Eur Heart J. 1999 Aug; 20(15):1084-93.
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study.
Carvalho PA, Vekshtein VI, Tumeh SS, Alajaji G, Nagel JS, Kirshenbaum J, DeSisto WC, Holman BL
Tc-99m MIBI SPECT in the assessment of myocardial reperfusion after percutaneous transluminal coronary angioplasty. Clin Nucl Med. 1991 Nov; 16(11):819-25.
Tc-99m MIBI SPECT in the assessment of myocardial reperfusion after percutaneous transluminal coronary angioplasty.
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI-IIIB trial. Circulation. 1994; 89:1545-1156.
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI-IIIB trial
Left main artery disease: noninvasive detection. Primary Cardiology. 1984; 10:87-101.
Left main artery disease: noninvasive detection
Hauptman PJ, Pashos CL, Kirshenbaum JM, Guadagnoli E, Flather MD
Clinical Dilemas and Policy Controversies in Early Management of Acute Myocardial Infarction. JCOM. 1995; 2:9-30.
Clinical Dilemas and Policy Controversies in Early Management of Acute Myocardial Infarction
Coronary angioplasty in acute myocardial infarction. J Myocardial Ischemia. 1991; 3:37-50.
Coronary angioplasty in acute myocardial infarction